149 related articles for article (PubMed ID: 34047135)
41. [Treating ischemic stroke patients of deficiency of qi and yin syndrome and static blood obstructing collaterals syndrome by Yangyin Yiqi Huoxue Recipe: a clinical study of therapeutic effect].
Wan HT; Bie XD; Yao Z; Xu B; Liu H; Yang JH; Zhang Y; He Y; Zhou HF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Mar; 35(3):281-6. PubMed ID: 25951630
[TBL] [Abstract][Full Text] [Related]
42. [A systematic review of the economic burden of influenza in China].
Zhu AQ; Zheng YM; Qin Y; Liu SS; Cui JZ; Li ZL; Li S; Feng LZ; Li ZJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Oct; 53(10):1043-1048. PubMed ID: 31607053
[No Abstract] [Full Text] [Related]
43. [Experts consensus statement on Qilong Capsules in clinical practice].
Wang ZF; Xie YZ; Xie YM; Zhao DX; Wang MZ; Yu HQ; Cao XL; Li B
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5287-5290. PubMed ID: 32237370
[TBL] [Abstract][Full Text] [Related]
44. Analysis of hospital charges for cerebral infarction stroke inpatients in Beijing, People's Republic of China.
Tu F; Tokunaga S; Deng Z; Nobutomo K
Health Policy; 2002 Mar; 59(3):243-56. PubMed ID: 11823027
[TBL] [Abstract][Full Text] [Related]
45. Factors influencing the hospitalization cost for stroke patients in J district, Shanghai.
Chen C; Zhu B; Chen Y; Yang T; Li F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):628-638. PubMed ID: 35753733
[TBL] [Abstract][Full Text] [Related]
46. Impact of universal medical insurance system on the accessibility of medical service supply and affordability of patients in China.
Xiong X; Zhang Z; Ren J; Zhang J; Pan X; Zhang L; Gong S; Jin S
PLoS One; 2018; 13(3):e0193273. PubMed ID: 29513712
[TBL] [Abstract][Full Text] [Related]
47. [Expert consensus statement on Diemailing~® Kudiezi Injection in clinical practice].
Liao X; Zhang YL; Xie YM; Shi DZ; Sun SL; Zou YH; Li J; Lu WX; Jin M; Liu HX; Tang XC; Jin XL; Ma YZ; Zhan SY; Liu JP; Chen YL
Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(14):2926-2931. PubMed ID: 31602834
[TBL] [Abstract][Full Text] [Related]
48. [Economic burden of coronary heart disease and stroke attributable to hypertension in China].
Zhai Y; Hu JP; Kong LZ; Zhao WH; Chen CM
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):744-7. PubMed ID: 17299955
[TBL] [Abstract][Full Text] [Related]
49. Utilization Pattern and Drug Use of Traditional Chinese Medicine, Western Medicine, and Integrated Chinese-Western Medicine Treatments for Allergic Rhinitis Under the National Health Insurance Program in Taiwan.
Huang SK; Lai CS; Chang YS; Ho YL
J Altern Complement Med; 2016 Oct; 22(10):832-840. PubMed ID: 27348711
[TBL] [Abstract][Full Text] [Related]
50. Characteristics and advantages of traditional Chinese medicine in the treatment of acute myocardial infarction.
Liu HX; Wang SR; Lei Y; Shang JJ
J Tradit Chin Med; 2011 Dec; 31(4):269-72. PubMed ID: 22462229
[TBL] [Abstract][Full Text] [Related]
51. A traditional Chinese medicine therapy for coronary heart disease after percutaneous coronary intervention: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Chen R; Xiao Y; Chen M; He J; Huang M; Hong X; Liu X; Fu T; Zhang J; Chen L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30143584
[TBL] [Abstract][Full Text] [Related]
52. Innovative Strategy in Treating Angina Pectoris with Chinese Patent Medicines by Promoting Blood Circulation and Removing Blood Stasis: Experience from Combination Therapy in Chinese Medicine.
Xiong XJ; Wang Z; Wang J
Curr Vasc Pharmacol; 2015; 13(4):540-53. PubMed ID: 25360837
[TBL] [Abstract][Full Text] [Related]
53. Big Data-Enabled Analysis of Factors Affecting Medical Expenditure in the Cerebral Infarction of a Developing City in Western China.
Zeng S; Zhang Y; Guo C; Zhou X; He X
Risk Manag Healthc Policy; 2023; 16():2703-2714. PubMed ID: 38107438
[TBL] [Abstract][Full Text] [Related]
54. Data Mining-Based Analysis of Modern Chinese Medicine for the Treatment of Stable Angina Pectoris in Coronary Heart Disease.
Luo M; Hu Y; Bai R; Xu Z
J Healthc Eng; 2022; 2022():3511974. PubMed ID: 35265297
[TBL] [Abstract][Full Text] [Related]
55. [Effect of Tripterygium Glycosides Tablets on immune-induced liver and kidney function in patients with rheumatoid arthritis based on data mining].
Dong WZ; Liu J; Xin L; Fang YY; Wen JT
Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(16):3526-3532. PubMed ID: 31602918
[TBL] [Abstract][Full Text] [Related]
56. Economic burden of cardiovascular diseases in China.
Yang L; Wu M; Cui B; Xu J
Expert Rev Pharmacoecon Outcomes Res; 2008 Aug; 8(4):349-56. PubMed ID: 20528342
[TBL] [Abstract][Full Text] [Related]
57. [Clinical comprehensive evaluation of Diemailing~® Kudiezi Injection in treatment of cerebral infarction].
Liu FM; Xie YM; Wang ZF; Zhang Q; Cui X
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6105-6113. PubMed ID: 34951238
[TBL] [Abstract][Full Text] [Related]
58. [Efficacy of Chinese Herbs for Supplementing Qi and Activating Blood Circulation on Patients with Acute Coronary Syndrome and Type 2 Diabetes Mellitus after Percutaneous Coronary Intervention: a Clinical Observation].
Du JP; Wang CL; Wang PL; Wang SL; Gao ZY; Zhang DW; Xu H; Shi DZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 May; 35(5):563-7. PubMed ID: 26159020
[TBL] [Abstract][Full Text] [Related]
59. [Core prescription excavation of launched Chinese patent medicines for treating different syndromes of angina pectoris].
Wei PL; Gu H; Guan S; Su YY; Liu Q; Liu J; Wang Z
Zhongguo Zhong Yao Za Zhi; 2019 Mar; 44(5):1041-1047. PubMed ID: 30989867
[TBL] [Abstract][Full Text] [Related]
60. [Expert consensus for Jiegu Qili Tablets (Capsules) in treatment of fracture in clinical practice].
Sun K; Xiong H; Yang HJ; Wei X; Zhu LG
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1976-1981. PubMed ID: 37282974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
